Orange County Business Journal

Edwards Comeback Continues on OK for Sapien XT

Edwards Lifesciences Corp.’s next generation of less-invasive heart valves is making its domestic debut, providing a boost that has extended a monthslong rally for shares of the Irvine-based heart ...
TCTMD

Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient Outcomes in 94 Center Post-Approval Study

Company Receives CE Mark Approval for 29 mm Transfemoral System First Human Experience With Next-Generation Valve Platforms to Be Presented PARIS-- Edwards Lifesciences Corporation, the global leader ...
TCTMD

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

IRVINE, CA. -- Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received CE Mark in Europe for valve-in-valve ...
Orange County Business Journal

Edwards Ready to Roll on Sapien Sales

Irvine-based Edwards Lifesciences Corp. is wasting no time getting its recently approved heart valve on the market here. Edwards Sapien is a less-invasive device that’s widely considered one of the ...
Business Wire

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...
Business Wire

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy ...
Nasdaq

Edwards Lifesciences SAPIEN 3 Heart Valve Data Positive

A leading player in the field of structural heart disease and critical care monitoring, Edwards Lifesciences CorporationEW recently unveiled positive one-year data on its SAPIEN 3 transcatheter heart ...
FierceBiotech

Edwards' next-gen Sapien heart valve gains Japanese reimbursement

Japan granted an insurance reimbursement for the Sapien XT valve.--Courtesy of Edwards Lifesciences Edwards Lifesciences' ($EW) Sapien heart-valve revenue engine gets ...
FierceBiotech

Edwards up 13% on Sapien TAVR data in intermediate-risk heart patients

CHICAGO--Edwards Lifesciences ($EW) is on track to be the first to meet the demand for TAVR implantation in an additional patient cohort following the success of the ...
Seeking Alpha

FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach ...
MD&M East

Edwards to Launch Sapien 3 In Europe

Edwards Lifesciences has received regulatory approval to sell its third-generation Sapien 3 transcatheter aortic heart valve in Europe. The news comes shortly after its rival Medtronic ended Edwards' ...